Cost Effectiveness of Spinal Cord Stimulation in the Management of Severe Angina
The majority of patients with angina pectoris often experience satisfactory pain relief through pharmacological treatment and/or surgery. Conventional medical management includes short-acting nitrates, beta-blockers, anticoagulants, angiotensin-converting enzyme inhibitors, long-acting nitrates, calcium-channel blockers and aspirin, whereas surgery includes coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). However, there is a group of patients that continues to suffer from lasting and severe and disabling angina pectoris despite optimum drug treatment and who are not suitable candidates for surgery. This condition has been defined as refractory angina pectoris .
KeywordsPercutaneous Coronary Intervention Coronary Artery Bypass Grafting Angina Pectoris Spinal Cord Stimulation Canadian Cardiovascular Society
- 2.ACC/AHA (2007) Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group. J Am Coll Cardiol 50: 2264–2274CrossRefGoogle Scholar
- 5.Simpson B (2003) Electrical stimulation and the relief of pain. Pain research and clinical management 15: 131–142Google Scholar
- 13.Simpson EL, Dueras A, Holmes MW et al (2009) Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess 13(17): iii, ix-x, 1–154Google Scholar
- 18.Dyer MT, Goldsmith KA, Khan SN et al (2008) Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial. Trials 9: 40PubMedCrossRefGoogle Scholar